Physiomics (LON:PYC) Trading Up 13.2% – Should You Buy?

Physiomics Plc (LON:PYCGet Free Report)’s share price shot up 13.2% during mid-day trading on Wednesday . The company traded as high as GBX 0.35 and last traded at GBX 0.32. 13,092,531 shares traded hands during trading, an increase of 392% from the average session volume of 2,662,833 shares. The stock had previously closed at GBX 0.28.

Physiomics Price Performance

The firm has a market capitalization of £903,562.82, a P/E ratio of -1.75 and a beta of 1.69. The firm’s 50 day moving average is GBX 0.31 and its two-hundred day moving average is GBX 0.40.

About Physiomics

(Get Free Report)

Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software. It also develops technology for use in the field of personalized medicine. The company was incorporated in 2001 and is based in Oxford, the United Kingdom.

Featured Articles

Receive News & Ratings for Physiomics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Physiomics and related companies with MarketBeat.com's FREE daily email newsletter.